Dana-Farber Brigham Cancer Center Foxborough

Foxborough, Massachusetts 02035

3 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, HER2-positive Breast Cancer, High-risk Smoldering Multiple Myeloma, Hormone Receptor Positive Breast Cancer, Intestinal Diseases, Intestinal Neoplasms

Studies at this site

• Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer — Recruiting now
• ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• DARA RVD For High Risk SMM — Running, not enrolling
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer — Running, not enrolling
• Culturally Aware AET Non-Initiation Intervention — Completed
• MARGetuximab Or Trastuzumab (MARGOT) — Running, not enrolling